A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of VGN-R08b in Patients With Type III Gaucher's Disease
Clinical trial NCT07603050 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07603050
- Sponsor
- Shanghai Vitalgen BioPharma Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-14
- Primary completion
- 2028-05-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.